TRCT
OPCH icon

Tower Research Capital (TRC)’s Option Care Health OPCH Stock Holding History

Tower Research Capital (TRC)’s Portfolio OPCH Stock Details OPCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$367K Buy
13,616
+5,085
+60% +$165K 0.01% 1150
2025
Q4 		$272K Sell
8,531
-8,849
-51% -$260K 0.01% 1222
2025
Q3 		$482K Sell
17,380
-13,827
-44% -$400K 0.01% 887
2025
Q2 		$1.01M Buy
31,207
+24,611
+373% +$795K 0.03% 541
2025
Q1 		$231K Sell
6,596
-4,546
-41% -$143K 0.01% 1290
2024
Q4 		$258K Buy
11,142
+7,082
+174% +$179K 0.01% 1541
2024
Q3 		$127K Sell
4,060
-48,754
-92% -$1.5M ﹤0.01% 2044
2024
Q2 		$1.46M Buy
52,814
+47,372
+870% +$1.41M 0.02% 551
2024
Q1 		$183K Sell
5,442
-24,535
-82% -$794K ﹤0.01% 1465
2023
Q4 		$1.01M Buy
29,977
+20,787
+226% +$639K 0.01% 854
2023
Q3 		$297K Buy
9,190
+913
+11% +$30.8K 0.01% 1192
2023
Q2 		$269K Buy
8,277
+2,331
+39% +$70.3K 0.01% 1363
2023
Q1 		$189K Sell
5,946
-1,106
-16% -$33.1K 0.01% 1400
2022
Q4 		$213K Sell
7,052
-8,971
-56% -$278K 0.01% 1263
2022
Q3 		$505K Buy
16,023
+5,993
+60% +$192K 0.01% 1131
2022
Q2 		$279K Buy
10,030
+4,657
+87% +$133K 0.01% 1537
2022
Q1 		$154K Sell
5,373
-1,223
-19% -$30.7K ﹤0.01% 1930
2021
Q4 		$188K Sell
6,596
-5,852
-47% -$154K ﹤0.01% 1817
2021
Q3 		$302K Buy
12,448
+6,459
+108% +$150K 0.01% 1402
2021
Q2 		$131K Sell
5,989
-3,003
-33% -$57.9K ﹤0.01% 2208
2021
Q1 		$160K Buy
8,992
+4,773
+113% +$89.4K ﹤0.01% 2188
2020
Q4 		$66K Sell
4,219
-33,811
-89% -$503K ﹤0.01% 2802
2020
Q3 		$508K Buy
38,030
+30,009
+374% +$365K 0.01% 1670
2020
Q2 		$111K Buy
+8,021
New +$106K ﹤0.01% 2366
2020
Q1 		– Sell
-194
Closed -$3K – 3647
2019
Q4 		$3K Sell
194
-794
-80% -$10.7K ﹤0.01% 2941
2019
Q3 		$13K Buy
988
+938
+1,876% +$11.5K ﹤0.01% 2775
2019
Q2 		$1K Sell
50
-184
-79% -$1.5K ﹤0.01% 3466
2019
Q1 		$2K Buy
+234
New +$3.08K ﹤0.01% 3437
2018
Q3 		– Sell
-225
Closed -$3K – 4119
2018
Q2 		$3K Sell
225
-2,410
-91% -$25.3K ﹤0.01% 3243
2018
Q1 		$26K Buy
2,635
+454
+21% +$5.25K ﹤0.01% 2038
2017
Q4 		$25K Buy
2,181
+159
+8% +$1.6K ﹤0.01% 1889
2017
Q3 		$22K Buy
2,022
+1,320
+188% +$14.9K ﹤0.01% 2678
2017
Q2 		$8K Buy
702
+298
+74% +$2.27K ﹤0.01% 1732
2017
Q1 		$3K Sell
404
-708
-64% -$4.68K ﹤0.01% 2483
2016
Q4 		$5K Sell
1,112
-3,034
-73% -$23.3K ﹤0.01% 3049
2016
Q3 		$48K Buy
+4,146
New +$44.7K ﹤0.01% 1168
2016
Q2 		– Sell
-39
Closed – – 4815
2016
Q1 		$0 Sell
39
-3,492
-99% -$26.2K ﹤0.01% 4697
2015
Q4 		$25K Buy
3,531
+1,344
+61% +$10.7K ﹤0.01% 1070
2015
Q3 		$17K Buy
2,187
+704
+47% +$7.11K ﹤0.01% 1887
2015
Q2 		$22K Buy
+1,483
New +$25.1K ﹤0.01% 2021
2015
Q1 		– Sell
-157
Closed -$4K – 4777
2014
Q4 		$4K Sell
157
-435
-73% -$10.8K ﹤0.01% 2897
2014
Q3 		$17K Buy
+592
New +$18.4K ﹤0.01% 2438
2014
Q2 		– Sell
-1,664
Closed -$46K – 4473
2014
Q1 		$46K Buy
1,664
+1,136
+215% +$35.1K 0.01% 1149
2013
Q4 		$16K Sell
528
-1,981
-79% -$56K ﹤0.01% 2554
2013
Q3 		$88K Buy
2,509
+1,722
+219% +$94.6K 0.01% 1413
2013
Q2 		$52K Buy
+787
New +$44.2K ﹤0.01% 907

Other funds holding OPCH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Tower Research Capital (TRC)'s OPCH Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Option Care Health (OPCH) stake by 60% in Q1 2026, buying an estimated $165K and bringing the position to 13,616 shares worth $367K. The position accounts for 0.01% of the portfolio, ranked #1150.

Tower Research Capital (TRC) first reported a position in OPCH in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.46M in Q2 2024. 369 funds tracked by Wall St. Rank hold OPCH as of Q1 2026.

  • Tower Research Capital (TRC) held 13,616 shares of Option Care Health worth $367K as of Q1 2026.
  • Tower Research Capital (TRC) bought 5,085 Option Care Health shares in Q1 2026, an estimated $165K.
  • Option Care Health made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1150 holding.
  • Tower Research Capital (TRC) first reported a position in Option Care Health in Q2 2013 and has held it in 46 quarters since.
  • Tower Research Capital (TRC)'s Option Care Health position peaked at $1.46M in Q2 2024.
  • 369 funds tracked by Wall St. Rank held Option Care Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.